MedPath

Impact of Sitagliptin on Diabetes Mellitus in Japanese elderly patients

Not Applicable
Conditions
Type2 Diabetes
Registration Number
JPRN-UMIN000009332
Lead Sponsor
Japan Physicians Association
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10000
Inclusion Criteria

Not provided

Exclusion Criteria

1. The patient who has an anamnesis of sitaglitin allergy 2. The patient who has used incretin related drug in the past 3 month 3. The patient who has severe ketosis, diabetic coma or pre coma in the past 6 month 4. The patient has severe infection, before or after operation or severe external injury 5. The patient who has severe renal dysfanction 6. The patient of Type1 diabetes 7. The patient who is undertaking with glinide class 8. The patient is not allowed to this study by attending physician

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath